Test Price
850 AED✅ Home Collection Available
West Nile Virus RNA Qualitative PCR in UAE | 850 AED | DHA-Licensed Molecular Diagnostics
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO-accredited real-time PCR processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM for blood samples. Cerebrospinal fluid collection is a hospital-only procedure.
Clinical Guidance: Complimentary telephonic post-test consultation for result interpretation by a DHA-licensed physician.
Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The West Nile Virus RNA Qualitative PCR test directly detects viral ribonucleic acid in serum, plasma, whole blood, or cerebrospinal fluid using gold-standard real-time PCR. This assay confirms acute infection within hours of symptom onset, enabling timely neurological intervention and public health reporting in accordance with UAE communicable disease surveillance protocols.
| Feature | Our Test (RNA PCR) | Closest Alternative (Serology IgM/IgG) |
|---|---|---|
| Precision | 99.9% analytical sensitivity; detects viral RNA directly | Cross-reactivity with other flaviviruses; delayed antibody rise |
| Methodology | Real-Time PCR (qPCR) with probe-based detection | Enzyme-linked immunosorbent assay (ELISA) |
| Turnaround Time | 3 working days (email); urgent phone result in 24 hours | 5–7 working days |
| Sample Types | Serum, plasma, whole blood, CSF | Serum only |
Physician Insight & Safety Protocols
“As a clinician, I recognise that neurological symptoms such as high fever, confusion, or limb weakness can be deeply concerning. This RNA PCR test offers the earliest available confirmation of West Nile virus infection. However, a negative result may still occur if testing is performed very early in the illness; clinical correlation remains essential. Please do not delay seeking emergency care based solely on a pending laboratory result.”
— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132
Important Advisory
Do not discontinue any prescribed medication without first consulting your treating physician. A laboratory result alone should not override clinical judgment or ongoing therapy.
Safety & Exclusion Criteria
Pre-Test Requirements & Exclusion Considerations
- Pre-test Requirements: A signed consent form and detailed clinical history are mandatory. Per Federal Decree-Law No. 4 of 2016 on Medical Liability, legal guardian consent is required for minor patients.
- Exclusion Considerations: Recent plasmapheresis or intravenous immunoglobulin (IVIG) therapy may produce false-negative results — please inform the laboratory in advance. Cerebrospinal fluid collection is performed exclusively by a licensed neurologist under strict aseptic conditions within an accredited hospital facility.
- Emergency Red Flags (seek immediate ER care): High fever exceeding 39°C, severe headache, neck stiffness, acute confusion, muscle weakness, or seizures.
Patient FAQ & Clinical Guidance
1. What does the West Nile Virus RNA Qualitative test detect?
The test identifies West Nile virus genetic material (RNA) in blood or cerebrospinal fluid, confirming acute infection. It is the earliest and most specific method to diagnose neuroinvasive disease, often ordered when symptoms such as high fever, severe headache, or limb weakness appear within 2–14 days after a mosquito exposure.
2. How should I prepare for the test, and when will I get results?
No fasting is required; simply bring your Emirates ID and any relevant medical reports or clinical history. Home sample collection is available daily from 8 AM to 11 PM for blood draws. Standard results are emailed on the 3rd working day, with an expedited phone notification possible within 24 hours for clinically urgent cases. Our team will verify insurance coverage via WhatsApp.
3. Is this test suitable for children or immunocompromised individuals?
Yes, the PCR method is safe and accurate regardless of age or immune status. For minors, Federal Decree-Law No. 4 of 2016 on Medical Liability mandates written guardian consent and a paediatric consultation before sample collection. Immunocompromised patients may exhibit atypical antibody responses, making RNA PCR the preferred diagnostic tool to avoid delays.
4. What happens if my result is positive?
A positive result confirms the presence of West Nile virus RNA. You will receive a complimentary telephonic consultation with a DHA-licensed physician to discuss clinical management, including symptom monitoring, supportive care, and neurology referral if neuroinvasive symptoms are present. Public health reporting will be conducted in accordance with UAE communicable disease protocols.
5. Can a negative result rule out West Nile virus infection completely?
A negative result significantly reduces the likelihood of acute infection but does not completely rule it out. Viral RNA may be undetectable in very early or late-stage illness. Serological testing for IgM and IgG antibodies may be recommended as a follow-up if clinical suspicion remains high. Always correlate laboratory findings with clinical presentation.
UAE Regulatory & Data Privacy Adherence
UAE Healthcare Compliance: This laboratory operates under DHA Facility License No. 1143, in full adherence with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical testing safety and patient consent procedures comply with Federal Decree-Law No. 4 of 2016 on Medical Liability. ISO 9001:2015 certified. Direct billing verification and support available via WhatsApp at +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | West Nile Virus RNA Qualitative PCR |
| Price (AED) | 850 |
| Turnaround Time | 3 working days (email); expedited phone result within 24 hours |
| Sample Type / Matrix | Serum, Plasma, Whole Blood, Cerebrospinal Fluid (CSF) |
| Methodology Used | Real-Time PCR (qPCR) with Fluorescent Probe Detection |
| ICD-10-CM Code | A92.3 |
| LOINC Code | 48411-2 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians